Article
Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen.
Cancer - 1 Mar 2009
Okishiro Masatsugu, Taguchi Tetsuya, Jin Kim Seung, Shimazu Kenzo, Tamaki Yasuhiro, Noguchi Shinzaburo
Abstract excerpt
BACKGROUND: The authors investigated the impact of the genetic polymorphisms cytochrome P450 (CYP) family 2, subfamily D, polypeptide 6, allele 10 (CYP2D6 10) and CYP family 2, subfamily C, polypeptide 19, allele 2, 3 (CYP2C19 2, 3) on disease recurrence in patients with breast cancer who receive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.